Investment firms 819 Capital Partners and LIOF have invested in I-Med Technology to advance its innovative 3D imaging systems for medical applications.
Target Company Information
I-Med Technology B.V., based in Maastricht, specializes in cutting-edge medical technology, particularly in the development of head-mounted 3D imaging systems. Founded in 2018 and located at the Brightlands Health Campus, the company aims to address critical challenges in medical and dental procedures where precision and speed are paramount. The firm's innovative Digital Head-mounted Microscope delivers Full HD, real-time 3D imaging, significantly enhancing procedural efficiency and safety.
The technology not only improves surgical accuracy but also serves as a powerful tool for medical training, education, and remote support. With systems certified under MDD and CE standards, I-Med is positioned to empower healthcare professionals with superior visualization capabilities that drive improved patient outcomes.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The Netherlands is a prominent player in the medical technology sector, characterized by a strong emphasis on innovation and research. With a highly developed healthcare system, the country is home to numerous companies specializing
Similar Deals
Frazier Life Sciences, Droia Ventures → Alesta Therapeutics
2025
Brightlands Venture Partners → Novenda Technologies
2023
819 Capital Partners, LIOF
invested in
I-Med Technology
in 2024
in a Series A deal